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ABSTRACT
Glutamic acid decarboxylase (GAD) is the enzyme responsible for 
the conversion of glutamate to gamma-aminobutyric acid (GABA) 
in the central nervous system. The presence of anti-GAD antibody 
in cerebrospinal fluid and high levels in blood have been described 
in some neurological disorders, such as stiff person syndrome and 
cerebellar ataxia. It is postulated that African descent with anti-GAD 
may exhibit more severe neurological impairment. We report a case 
of a young adult African descent with cerebellar syndrome associ-
ated with ophthalmoplegia and laryngeal stridor. We found in the 
literature relationship of ophthalmoplegia plus ataxia with anti-GAD, 
but no reports of these symptoms with laryngeal stridor, apparently 
being the first reported case. 
Keywords: Ataxia, ophthalmoplegia, glutamic acid decarboxylase, 
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RESUMO
Descarboxilase do ácido glutâmico (GAD) é a enzima responsável 
pela conversão do glutamato em ácido gama-aminobutírico (GABA) 
no sistema nervoso central. A presença do anticorpo anti-GAD no 
líquido cefalorraquidiano e em altos níveis no sangue tem sido des-
crita em alguns distúrbios neurológicos, tais como a síndrome da 
pessoa rígida e ataxia cerebelar. Postula-se que pacientes afrodes-
cendentes podem apresentar comprometimento neurológico mais 
severo. Relatamos o caso de um adulto jovem afrodescendente com 
síndrome cerebelar associada a oftalmoplegia e estridor laríngeo. 
Encontramos na literatura relação entre a oftalmoplegia com ataxia 
e anti-GAD, mas nenhum relato desses sintomas com estridor larín-
geo, sendo aparentemente o primeiro caso reportado. 
Palavras-chave: Ataxia, oftalmoplegia, descarboxilase do ácido 
glutâmico, GAD, anti-GAD, estridor laríngeo.
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INTRODUCTION
Glutamic acid decarboxylase (GAD) is the enzyme 
responsible for conversion of glutamate in gamma-
aminobutyric acid in the central nervous system 
(CNS).1 It is also found in pancreatic beta cells and 
type 1 diabetes mellitus (DM) that could be related 
to the presence of anti-glutamic acid decarboxylase 
(anti-GAD) antibodies.2-4
The presence of anti-GAD in cerebrospinal fluid 
(CSF) and high levels in blood have been described 
in some neurological disorders, such as stiff person 
syndrome and cerebellar ataxia.5-7 It is postulated 
that African descent patients may exhibit more severe 
neurological impairment.8
We report a case of a young adult, African descent 
with progressive cerebellar syndrome associated with 
ophthalmoplegia and laryngeal stridor.
CASE REPORT
A 20 years-old African-Brazilian man started four 
years earlier with diplopia, gait ataxia with frequent 
falls, impaired speech (slurred speech), and sharp 
sound on breathing, compatible with stridor. 
The neurological examination showed intermit-
tent stridor, severe gait ataxia with truncal tituba-
tion, head tremor (no-no), slurred speech, bilateral 
and complete ophthalmoparesis with non-reactive 
mydriatic pupils.
He denied family history of neurological condi-
tions, use of illicit drugs, alcohol and previous expo-
sure to toxins.
Initial investigation (blood levels of glucose, vita-
mins B1, B12 and E, thyroid function, and serologi-
cal tests for HIV and syphilis) were within normal 
range/negative. 
Magnetic resonance imaging (MRI) of the brain 
revealed cerebellar atrophy (Figure 1). Electromyog-
raphy with repetitive stimulation test was normal.
Tests for spinocerebellar ataxia type 1, 2, 3, 6, 7, 
10, and 12, Friedreich’s ataxia, Dentatorubral-pallido-
luysian atrophy (DRPLA) were all negative, as well as 
anti-endomysial antibodies and anti-transglutaminase.
Levels of anti-GAD were positive in blood 
(3,4 U/mL; normal value < 1,0 U/mL), and in CSF 
(1,17 U/mL; normal value < 1,0 U/ml). Oligoclo-
nal bands were also detected in the CSF.
Methylprednisolone therapy was prescribed 
(1 g/day, for 5 days), without improvement, fol-
lowed by two monthly courses of human immuno-
globulin (400 mg/kg/day, for 5 days), with partial 
improvement of ataxia as well as of the laryngeal stri-
dor. About eight months after starting treatment the 
patient had high fever with respiratory distress and 
obitus in an another institution.
Figure 1. Brain MRI sagittal sequence revealing cerebellar atrophy.
DISCUSSION 
We present a case of a young African-Brazilian man 
with high levels of anti-GAD that presented insidious 
painless ophthalmoplegia, and developed severe ata-
xia with impairment of speech, and laryngeal stridor.
The MRI guided the initial research to genetic 
causes. Researches for hereditary ataxias were per-
formed, but all were negative.
Levels of anti-GAD were high in the blood and 
present in the CSF, establishing the diagnosis of ataxia-
ophthalmoplegia-laryngeal stridor due to anti-GAD.
It is known that GABAergic neurons are widely 
distributed in the CNS and anti-GAD disorders can 
produce various symptoms in the brainstem, extra-
pyramidal system and spinal cord. The cause of more 
severe symptoms in African descent is unclear.8 Our 
patient confirmed this finding, considering that he 
presented a severe global ataxia with impairment of 
the basic activities of daily living, complete ophthal-
moplegia, and laryngeal stridor.
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Anti-GAD syndrome
We found in the literature reports of ophthalmo-
plegia plus ataxia with anti-GAD, but without the 
presence of laryngeal stridor, being this case, appar-
ently, the first one reported.
The treatment is based on immunosuppressive 
therapy, with variable degrees of response.9,10 Our pa-
tient received methylprednisolone without satisfac-
tory results, but presented partial improvement with 
human immunoglobulin.
We concluded that it is important to consider this 
diagnosis, considering it is a treatable condition, and 
that African descent patients may present more severe 
neurological manifestations related to anti-GAD. 
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